Found 0 matching trials
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis PHASE3 Primary objective was to assess the effectiveness evaluated by the time to ...
Show More Location
Investigational Site Number 056003
Learn More & Join Trial
COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS N/A A phase IV, observational, survey-based study to measure compliance with Av...
Show More Location
University Hospital, London Health Sciences Centre
Learn More & Join Trial
A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis PHASE3 General Note: throughout this record, "Rebif® New Formulation" is used for ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS) PHASE2 The primary objectives of the study are to evaluate the safety of BIIB061 v...
Show More Location
Multiple Locations
Learn More & Join Trial
Avonex®: Safety, Blood Levels and Effects PHASE1 The primary objective was to determine the tolerability of a new inhaled fo...
Show More Location
Hammersmith Medicines Research
Learn More & Join Trial
MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia PHASE4 This is a cross sectional Phase 4, multicenter, study of AVONEX® and JUMTAB...
Show More Learn More & Join Trial
Early Interferon-beta Treatment for West-Nile Virus Infection PHASE2 West Nile virus (WNV) is a mosquito-borne virus which in majority of cases ...
Show More Location
Tel-Aviv Sourasky Medical Center
Learn More & Join Trial
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change PHASE4 The purpose of this study is to evaluate the change in patient-reported tre...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate) N/A The primary objectives of the study are to estimate the risk of major conge...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. N/A This observational multicentric study is planned to assess the tolerability...
Show More Location
Merck Serono Research Site
Learn More & Join Trial